Ribomic, Inc.

37
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3974850004
JPY
59.00
1 (1.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Ribomic, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-1,144.00
-1,017.00
-1,023.00
-1,651.00
-1,683.00
-1,185.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
10.00
12.00
33.00
-55.00
133.00
-11.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-1,110.00
-996.00
-932.00
-1,708.00
-1,499.00
-1,149.00
Cash Flow from Investing Activities
289.00
67.00
177.00
276.00
689.00
-1,699.00
Cash Flow from Financing Activities
911.00
667.00
27.00
1,333.00
354.00
4,988.00
Net Cash Inflow / Outflow
90.00
-262.00
-725.00
-76.00
-436.00
2,138.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
2.00
21.00
18.00
-1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ribomic, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-1144.15
-676.253
-468.00
-69.19%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
10.9
23.554
-13.00
-53.72%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-1110.863
-581.138
-529.00
-91.15%
Cash Flow from Investing Activities
289.832
-5.514
294.00
5356.29%
Cash Flow from Financing Activities
911.054
1065.666
-154.00
-14.51%
Net Cash Inflow / Outflow
90.057
463.707
-373.00
-80.58%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.033
-15.307
15.00
100.22%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -11.42% vs -6.88% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
-1,110.86
-996.97
-11.42%